Questions with the most recent answer or edit.
Details up front: potassium · survodutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
Conditions: TFC · Wuhan Wansheng Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works;…
For reference: fatigue · 1,000 kcal. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within what I understood…
Stated plainly: retatrutide · 3.33 mg/mL. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my…
What I have: Tianjin · the United Kingdom. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Setup, so nobody has to ask: lot-specific certificate · KP. I have read the primary source rather than the summary, which has left me with more questions. I…
I have been on a stable schedule for eleven weeks, so this is not a first-week question. I have the document in front of me and I can read the numbers. What I cannot…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I want to know whether this is a real physical effect or an artefact of…
The case in front of me: ecnoglutide · 20 mg/mL. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one…
For reference: dizziness · semaglutide · STEP 5. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that…
The case in front of me: nausea · four · semaglutide. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the…
Concretely: TFC · liraglutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether this is…
Stated plainly: SWB · Qingdao Sigma Chemical. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible…
The particulars: dulaglutide · three days. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather…
I would rather spend on verification than on volume. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if…
What I am working with: cystatin C · semaglutide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on…
Details up front: 15 mg · sixteen weeks · injection-site erythema. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I…
For reference: 10 units · 2.5 mg/mL. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than discover a problem…
Numbers first: mazdutide · six weeks · minus 80 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to…
For reference: eGFR · dulaglutide. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
The specifics, since they change the answer: an 18G drawing needle · survodutide · 2 mg/mL. The comparison I want does not seem to exist anywhere in a form I can…
Details up front: 96.8% · orforglipron. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method…
For reference: oral semaglutide · 37 °C. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…
Details up front: STEP 4 · 2 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree, which…